Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age

This publication has 19 references indexed in Scilit:

• Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years
  British Journal of Haematology, 2001
• Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation
  Bone Marrow Transplantation, 2001
• Autologous blood and marrow transplantation in patients 60 years and older.
  Transplantation and Cellular Therapy, 2000
• The role of autologous transplantation in patients with multiple myeloma aged 65 years and over
  Bone Marrow Transplantation, 2000
• Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients
  Blood, 1999
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
  Statistics in Medicine, 1999
• Age Is Not a Prognostic Variable With Autotransplants for Multiple Myeloma
  Blood, 1999
• CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
  British Journal of Haematology, 1998
• Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma
  Bone Marrow Transplantation, 1998
• A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
  New England Journal of Medicine, 1996